These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Skin-credible: skin cells used to generate neurons damaged by Parkinson’s disease. Regen Med; 2012 Sep; 7(5):631-2. PubMed ID: 22954432 [No Abstract] [Full Text] [Related]
27. Future and current surgical therapies in Parkinson's disease. Betchen SA; Kaplitt M Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808 [TBL] [Abstract][Full Text] [Related]
28. Brain repair and reprogramming: the route to clinical translation. Grealish S; Drouin-Ouellet J; Parmar M J Intern Med; 2016 Sep; 280(3):265-75. PubMed ID: 27539906 [TBL] [Abstract][Full Text] [Related]
29. Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice. Bye CR; Thompson LH; Parish CL Exp Neurol; 2012 Jul; 236(1):58-68. PubMed ID: 22524988 [TBL] [Abstract][Full Text] [Related]
30. Embryonic stem cells as a cell source for treating Parkinson's disease. Fukuda H; Takahashi J Expert Opin Biol Ther; 2005 Oct; 5(10):1273-80. PubMed ID: 16197334 [TBL] [Abstract][Full Text] [Related]
31. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774 [TBL] [Abstract][Full Text] [Related]
32. Dopaminergic transplantation for Parkinson's disease: current status and future prospects. Olanow CW; Kordower JH; Lang AE; Obeso JA Ann Neurol; 2009 Nov; 66(5):591-6. PubMed ID: 19938101 [TBL] [Abstract][Full Text] [Related]
35. Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era. Barker RA; Parmar M; Studer L; Takahashi J Cell Stem Cell; 2017 Nov; 21(5):569-573. PubMed ID: 29100010 [TBL] [Abstract][Full Text] [Related]
39. The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease. Ratzka A; Kalve I; Özer M; Nobre A; Wesemann M; Jungnickel J; Köster-Patzlaff C; Baron O; Grothe C Cell Transplant; 2012; 21(4):749-62. PubMed ID: 21929871 [TBL] [Abstract][Full Text] [Related]
40. Restorative approaches in Parkinson's Disease: which cell type wins the race? Meyer AK; Maisel M; Hermann A; Stirl K; Storch A J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]